• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Twist Bioscience Corporation

    < Previous 1 2 3 4 5 Next >
    Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Expands Express Genes Rapid Synthesis Service
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience to Present at Upcoming Investor Conferences
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Appoints Chet Gandhi as Chief Information Officer
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience to Present at Upcoming Investor Conferences
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Launches Portfolio of RNA Sequencing Tools
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience to Present at ITF World 2023
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
    From Twist Bioscience Corporation
    Via Business Wire
    Tickers TWST
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.